SIRT1 and metabolic dysfunction-associated steatotic liver disease: In the PA + OA-induced in vitro NAFLD model, miR-667-5p could promote the levels of TG (Fig. 5F) and TC (Fig. 5G) in Hepa1-6 cells, which were reversed by SIRT1 overexpression (P < 0.05).